Developing new products to prevent HIV in children
Official title: Resources to Advance Pediatrics and HIV Prevention Science (RAPPS): Animal Models Supporting Product Development
Funded at Tulane University of Louisiana · NIH-10850754 · Data updated 2026-11-12
This study is working to create new ways to prevent and treat HIV in kids and teens, helping researchers find better options that can be tested in real life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | April 15, 2023 |
| Project end | April 14, 2028 |
| Funding year | 2023 |
| Award (this year) | $21,632 |
| NIH project number | 75N93023D00003-0-759302300001-1 |
| Project ID | NIH-10850754 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include children and adolescents at risk for HIV infection.
✕Less likely to help
Patients who are not at risk for HIV or those who are already living with HIV may not receive direct benefits from this research.
What this research studies
This research aims to support the development of new therapeutic and prevention products for HIV, particularly focusing on pediatric populations. It provides essential resources and materials to researchers working on innovative solutions, including contraceptive agents and combination therapies. By collaborating with academic and private sector partners, the project seeks to expedite the process of bringing promising products from the lab to clinical testing. Patients may benefit from advancements in HIV prevention strategies tailored for children and adolescents.
Why it matters
Potential benefit: If successful, this research could lead to effective HIV prevention products specifically designed for pediatric patients.
How similar studies have gone: Previous research has shown success in developing HIV prevention strategies, but this specific approach focusing on pediatric populations is relatively novel.
Where this research is happening
-
Tulane University of Louisiana
New Orleans, United States Active
Researchers
- Principal investigator: Veazey, Ronald — Tulane University of Louisiana
- Study coordinator: Veazey, Ronald
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Adolescent girls in Uganda: a long-term look at how money empowerment and family support affect HIV prevention, care, and mental health
A long-term study in rural Uganda will test whether an intervention that combines economic empowerment and family strengthening can help HIV-negative and HIV-affected adolescent girls move safely into young adulthood.
-
Long-term HIV prevention and mental health support for adolescent girls and young women in Uganda
A long-term program in rural Uganda tests if combining economic support and family strengthening helps teenage girls stay HIV-free and improve mental health as they grow into young adults.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.